Tandem Diabetes Care, Inc. (TNDM)
16.12
-0.04
(-0.25%)
USD |
NASDAQ |
Oct 07, 12:35
Tandem Diabetes Care EPS Diluted (Quarterly) : -0.3067 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3067 |
| March 31, 2026 | -0.2982 |
| December 31, 2025 | -0.0087 |
| September 30, 2025 | -0.3128 |
| June 30, 2025 | -0.7815 |
| March 31, 2025 | -1.966 |
| December 31, 2024 | 0.0114 |
| September 30, 2024 | -0.3548 |
| June 30, 2024 | -0.4741 |
| March 31, 2024 | -0.6539 |
| December 31, 2023 | -0.459 |
| September 30, 2023 | -0.5062 |
| June 30, 2023 | -0.5518 |
| March 31, 2023 | -1.919 |
| December 31, 2022 | -0.2462 |
| September 30, 2022 | -0.7624 |
| June 30, 2022 | -0.235 |
| March 31, 2022 | -0.2304 |
| December 31, 2021 | 0.1639 |
| September 30, 2021 | 0.0894 |
| June 30, 2021 | 0.061 |
| March 31, 2021 | -0.0808 |
| December 31, 2020 | 0.2588 |
| September 30, 2020 | -0.1529 |
| June 30, 2020 | -0.4486 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2489 |
| December 31, 2019 | 0.0422 |
| September 30, 2019 | -0.0493 |
| June 30, 2019 | -0.026 |
| March 31, 2019 | -0.398 |
| December 31, 2018 | 0.0606 |
| September 30, 2018 | -0.6158 |
| June 30, 2018 | -1.17 |
| March 31, 2018 | -1.82 |
| December 31, 2017 | -1.23 |
| September 30, 2017 | -3.090 |
| June 30, 2017 | -4.40 |
| March 31, 2017 | -74.60 |
| December 31, 2016 | -4.80 |
| September 30, 2016 | -9.70 |
| June 30, 2016 | -6.00 |
| March 31, 2016 | -6.80 |
| December 31, 2015 | -4.00 |
| September 30, 2015 | -6.50 |
| June 30, 2015 | -6.50 |
| March 31, 2015 | -8.30 |
| December 31, 2014 | -7.80 |
| September 30, 2014 | -8.50 |
| June 30, 2014 | -8.30 |
| March 31, 2014 | -9.60 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Senseonics Holdings, Inc. | -0.6346 |
| Abbott Laboratories | 0.5324 |
| Accuray, Inc. | -0.0154 |
| DexCom, Inc. | 0.6429 |
| Micron Solutions, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.17M |
| Revenue (Quarterly) | 254.14M |
| Total Expenses (Quarterly) | 275.31M |
| Enterprise Value | 1.407B |
| Gross Profit Margin (Quarterly) | 56.80% |
| Profit Margin (Quarterly) | -8.33% |
| Earnings Yield | -5.75% |
| Normalized Earnings Yield | -5.567 |